Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20701 - 20725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cyclophosphamide	Approved Investigational	DUSP10	11221	downregulated	Cyclophosphamide metabolite results in decreased expression of DUSP10 mRNA	1q41	A20727
Cyclophosphamide	Approved Investigational	DZIP1	22873	upregulated	Cyclophosphamide results in increased expression of DZIP1 mRNA	13q32.1	A21865
Cyclophosphamide	Approved Investigational	EDA2R	60401	upregulated	Cyclophosphamide results in increased expression of EDA2R mRNA	Xq12	A21863
Cyclophosphamide	Approved Investigational	EDNRB	1910	upregulated	Cyclophosphamide results in increased expression of EDNRB mRNA	13q22.3	A20660
Cyclophosphamide	Approved Investigational	EGR1	1958	upregulated	Cyclophosphamide results in increased expression of EGR1 mRNA	5q31.2	A21863
Cyclophosphamide	Approved Investigational	EMP1	2012	upregulated	Cyclophosphamide results in increased expression of EMP1 mRNA	12p13.1	A21863
Cyclophosphamide	Approved Investigational	EMP3	2014	upregulated	Cyclophosphamide results in increased expression of EMP3 mRNA	19q13.33	A21863
Cyclophosphamide	Approved Investigational	EPB41L2	2037	downregulated	Cyclophosphamide results in decreased expression of EPB41L2 mRNA	6q23.1-q23.2	A21865
Cyclophosphamide	Approved Investigational	ERG	2078	upregulated	Cyclophosphamide results in increased expression of ERG mRNA	21q22.2	A21865
Cyclophosphamide	Approved Investigational	EVI2A	2123	downregulated	Cyclophosphamide metabolite results in decreased expression of EVI2A mRNA	17q11.2	A20727
Cyclophosphamide	Approved Investigational	F3	2152	downregulated	Cyclophosphamide results in decreased expression of F3 mRNA	1p21.3	A21865
Cyclophosphamide	Approved Investigational	FAM107B	83641	downregulated	Cyclophosphamide metabolite results in decreased expression of FAM107B mRNA	10p13	A20727
Cyclophosphamide	Approved Investigational	FAS	355	downregulated	Cyclophosphamide metabolite results in decreased expression of FAS mRNA	10q23.31	A20727
Cyclophosphamide	Approved Investigational	FKBPL	63943	upregulated	Cyclophosphamide results in increased expression of FKBPL mRNA	6p21.32	A21866
Cyclophosphamide	Approved Investigational	FLNC	2318	upregulated	Cyclophosphamide results in increased expression of FLNC mRNA	7q32.1	A21863
Cyclophosphamide	Approved Investigational	FSCN1	6624	upregulated	Cyclophosphamide results in increased expression of FSCN1 mRNA	7p22.1	A21865
Cyclophosphamide	Approved Investigational	FYN	2534	upregulated	Cyclophosphamide results in increased expression of FYN mRNA	6q21	A21865
Cyclophosphamide	Approved Investigational	GLOD4	51031	downregulated	Cyclophosphamide results in decreased expression of GLOD4 mRNA	17p13.3	A20660
Cyclophosphamide	Approved Investigational	GLRB	2743	upregulated	Cyclophosphamide results in increased expression of GLRB mRNA	4q32.1	A21865
Cyclophosphamide	Approved Investigational	GLS	2744	upregulated	Cyclophosphamide results in increased expression of GLS mRNA	2q32.2	A21863
Cyclophosphamide	Approved Investigational	GNG12	55970	upregulated	Cyclophosphamide results in increased expression of GNG12 mRNA	1p31.3	A21865
Cyclophosphamide	Approved Investigational	GPR137B	7107	upregulated	Cyclophosphamide results in increased expression of GPR137B mRNA	1q42.3	A21863
Cyclophosphamide	Approved Investigational	GPR18	2841	downregulated	Cyclophosphamide metabolite results in decreased expression of GPR18 mRNA	13q32.3	A20727
Cyclophosphamide	Approved Investigational	GPR20	2843	upregulated	Cyclophosphamide results in increased expression of GPR20 mRNA	8q24.3	A20660
Cyclophosphamide	Approved Investigational	GPT2	84706	downregulated	Cyclophosphamide metabolite results in decreased expression of GPT2 mRNA	16q11.2	A20727

Displaying entries 20701 - 20725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability